Related Experiment Video

Updated: Aug 6, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Factors associated with low-density lipoprotein control in outpatients with myocardial infarction: A hospital-based

Anan S Jarab1, Walid Al-Qerem2, Razan Mansour1

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Plos One
|July 16, 2026
PubMed

Insights

Most myocardial infarction (MI) patients have uncontrolled low-density lipoprotein cholesterol (LDL-C). Smoking, beta-blocker use, and uncontrolled blood pressure predict poor LDL-C control, necessitating targeted management strategies for better cardiac outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Suboptimal low-density lipoprotein cholesterol (LDL-C) control is a significant concern in myocardial infarction (MI) patient management.
  • Identifying factors influencing LDL-C control is vital for developing effective interventions to improve cardiovascular outcomes.

Purpose of the Study:

  • To assess LDL-C control status in MI patients.
  • To identify predictors of uncontrolled LDL-C in this population.

Main Methods:

  • Retrospective data collection from medical records of MI patients in an outpatient cardiology clinic.
  • Utilized validated Arabic scales for medication adherence and beliefs.
  • Employed binary logistic regression to determine predictors of LDL-C control.

Main Results:

  • A high prevalence of uncontrolled LDL-C was observed in 76.6% of the 255 patients studied.
  • Independent predictors of uncontrolled LDL-C included current smoking (OR=2.006), beta-blocker prescription (OR=2.211), and uncontrolled blood pressure (OR=1.940).

Conclusions:

  • Effective management strategies are crucial for improving LDL-C control in MI patients to reduce cardiac complications.
  • Interventions should focus on smoking cessation and optimizing blood pressure control to enhance patient health outcomes.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...